World Cancer Day: From Survivor to Supporter
On World Cancer Day, it is important to remember that cancer care does not end with surgery or chemotherapy - Rashi Kapoor of Sachin Sarcoma shares her thoughts.
Bridging the Gaps in GIST Care
GIST patients often face unequal care due to gaps in specialist access, biomarker testing, and education, underscoring the need to make expert, equitable treatment the standard rather than the exception.
Sarcoma – The Cancer No One Talks About
Sarcoma is a rare, often overlooked cancer that demands greater awareness, early specialist care, and stronger support so patients do not face the disease alone.
Health Equity Council Update 10-3-25
The Life Raft Group Health Equity Council meets biweekly to discuss strategies for ensuring that all patients have equitable access to healthcare and resources. This is an update from the past two meetings.
Manual de Nutrición Oncológica
This summer, GIST Chile released a cookbook in Spanish made with cancer patients in mind, filled with recipes for nourishment, comfort, and care.
The Global Advocate Academy Course (GAAC)
The New Horizons GIST Consortium has created a Global Advocate Academy Course (GAAC) targeted towards GIST patients, caretakers, oncologists, researchers, and organization representatives located worldwide.
Importancia del diagnóstico molecular en el GIST
El diagnóstico molecular en GIST impulsa tratamientos personalizados y más eficaces, dando forma al futuro de la precisión en la medicina.
Impact of Molecular Diagnosis in GIST
Molecular diagnosis in GIST drives personalized, more effective treatments, shaping the future of precision medicine.
Annual Bigman & Etzi Memorial Tailgate Raises Funds for The Life Raft Group
The family and friends of late LRG Board member Eric Biegansky. Eric's wife, Jill, and his kids, Ryan and Emma, along with dozens of Eric's friends gathered for a fundraiser in his memory.
Patient of the Month – July 2024: Tom Tiefert
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Tom Tiefert shares his story.